Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Marijuana Abuse 3Pain 2Neoplasms 2Glioblastoma 2Signs and Symptoms 1Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Nausea 1Marijuana Use 1Cancer Pain 1Cachexia 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 11- Cancer Patients During Chemotherapy Treatment 1

Interventions

Megestrol Acetate 7Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Enteral Nutrition 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1bermekimab 1anamorelin 1Vitamin D 1Ultrasonography 1Retrospective Studies 1Radiotherapy 1Powders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cachexia × nabiximols × Clear all
NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn
Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡